Download Document

BIBLIOGRAPHY 2013
Module 1
Akbik H, Butler SF, Budman SH, et al. Validation and clinical application of the Screener and Opioid
Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006;32(3):287-293.
American Academy of Pain Medicine www.painmed.org
American Geriatrics Society Panel. Pharmacological management of persistent pain in older persons.
JAGS 2009;57:1331-1346.
Apkarian AV et al. Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts
cytokine interactions in the hippocampus. Pain 2011 Dec; 152 (3 Suppl): S49-S64.
Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003 Nov 13;349(20):1943-53.
Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory
processing in fibromyalgia. Mayo Clin Proc 1999;74:385-398.
Benyamin R, et al. Opioid complications and side effects. Pain Physician 2008; 11:S105-S120.
Brevik H et al. Assessment of Pain. Br J Anaesh 2008;101:17-24.
Bruehl, S et al. Personalized Medicine and Opioid Analgesic Prescribing for Chronic Pain: Opportunities
and Challenges. The Journal of Pain, Vol 14, No 2 (February), 2013: pp 103-113.
CDC. Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010.
Morbidity and Mortality Weekly Report (MMWR) July 6, 2012 / 61(26);493-497.
Cheatle M, Gallagher R. Chronic pain and comorbid mood and substance use disorders: a
biopsychosocial treatment approach. Curr Psychiatry Rep. 2006 Oct;8(5):371-6.
Dahan A, et al. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
Anesthesiology 2010;112:226-238.
Dersh J, Polatin PB, Gatchel RJ. 2002 Chronic pain and psychopathology: Research findings and
theoretical considerations. Psychosomatic Medicine 64:773-786.
Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic
pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA.
2005 Jun 22;293(24):3043-52.
Evers GC, et al. Pseudo-opioid-resistant pain. Support Care Cancer. 1997 Nov;5(6):457-60.
FDA Blueprint. Introduction for the FDA Blueprint for Prescriber Education for Extended-Release and
Long-Acting Opioid Analgesics . Jul 2012.
www.fda.gov/downloads/drugs/drugsafety/informationbydrugclass/ucm277916.pdf
Fischer-Kern M, et al. The relationship between personality organization and psychiatric classification in
chronic pain patients. Psychopathology. 2011;44(1):21-6.
Fredheim OMS et al. Clinical pharmacology of methadone for pain. Acta Anaestheiol Scand.
2008;52:879-889.
Furlan AD, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.
CMAJ. 2006 May 23;174(11):1589-94.
Gatchel RJ. Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective.
Am Psychol. 2004 Nov;59(8):795-805.
Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007
Jul;11(5):490-518.
Institute of Medicine. 2011 Relieving Pain in America. Washington DC.
Ives J, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC
Health Serv Res. 2006 Apr 4;6:46.
Kelso E, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004
Dec;112(3):372-80.
Knaster P, Karlsson H, Estlander A, Kalso E. 2012 Psychiatric disorders as assessed with SCID in chronic
pain patients: the anxiety disorders precede the onset of pain. General Hospital Psychiatry 34(1):46-52.
January 2012
Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Science and
Practice Perspectives – July 2002:13-20.
Krebs EE et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity
and interference. Gen Intern Med 2009;24(6):733-8.
Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression
screener. Med Care. 2003 Nov;41(11):1284-92.
Liebschutz JM et al. Clinical factors associated with prescription drug use disorder in urban primary care
patients with chronic pain. J Pain. 2010 Nov;11(11):1047-55.
McCleane G, Smith HS. Opioids for persistent noncancer pain. Med Clin North Am. 2007 Mar;91(2):17797.
Michna E, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of
abuse history. J Pain Symptom Manage. 2004 Sep;28(3):250-8.
Moore TM, et al. A comparison of common screening methods for predicting aberrant drug-related
behavior among patients receiving opioids for chronic pain management. Pain Medicine 2009;10(8):
1426-1433.
National Vital Statistics System, 1999-2008; Automation of Reports and Consolidated Orders System
(ARCOS) of the Drug Enforcement Administration (DEA), 1999-2010; Treatment Episode Data Set, 19992009.
Noble M, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev.
2010 Jan 20;(1):CD006605.
Otis JD, Gregor K, Hardway C. 2010 An examination of the co-morbidity between chronic pain and
posttraumatic stress disorder on U.S. veterans. Psychological Services .
Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc. 2009
Jul;84(7):593-601.
Perrone J, Nelson LS. Medication reconciliation for controlled substances--an "ideal" prescription-drug
monitoring program. N Engl J Med 2012; 366:25:2341-2343.
Polatin PB, Kinney RK., Gatchel RJ, Lillo E, Mayer TG. 1993 Psychiatric illness and chronic low-back pain.
Spine 18(1):66-71
Reid MC, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen
Intern Med. 2002 Mar;17(3):173-9.
SAMSHA, 2009 National Survey on Drug Use and Health (September 2010).
2010 National Survey on Drug Use and Health: SAMHSA, Office of Applied Studies; 2011
Saunders KW, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain
patients. J Gen Intern Med. 2010;25:310-315.
Smith HS. Variations in opioid responsiveness. Pain Physician 2008;11: 237-248.
Smith HS. Opioid metabolism. Mayo Clin Proc. 2009 Jul;84(7):613-24.
Smith PC, et al. Primary care validation of a single-question alcohol screening test. Gen Intern Med. 2009
Jul;24(7):783-8.
Smith PC, et al. A single-question screening test for drug use in primary care. Arch Intern Med. 2010 Jul
12;170(13):1155-60.
Stanos SP et al. Strategies to reduce the tampering and subsequent abuse of long-acting opioids:
potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.
Mayo Clin Proc. 2012;87(7):683-694.
The Medical Letter. Drugs for pain. Treatment Guidelines from the Medical Letter. 2010 Apr 1;8(92):2534.
Trescot AM et al. Opioid pharmacology. Pain Physician 2008;11:S133-S153.
Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic
pain in community clinic populations. J Gen Intern Med. 2006 Jun;21(6):652-5.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary
validation of the Opioid Risk Tool. Pain Med. 2005 Nov-Dec;6(6):432-42.
Module 2
Argoff CE, Silvershein DI. A comparison of long- and short-acting opioids for the treatment of chronic
noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc. 2009 Jul;84(7):602-12.
Arnold RM, Han PK, Seltzer D. Opioid contracts in chronic nonmalignant pain management: objectives
and uncertainties. Am J Med. 2006 Apr;119(4):292-6.
Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003 Nov 13;349(20):1943-53.
Berndt S, et al. Polymedication and medication compliance in patients with chronic non-malignant pain.
Pain 1993
Bohnert AS, et al. Association between opioid prescribing patterns and opioid overdose-related deaths.
JAMA. 2011 Apr 6;305(13):1315-21.
Braden JB. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med.
2010 Sep 13;170(16):1425-32.Brush DE. Complications of long-term opioid therapy for management of
chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. 2012 Dec;8(4):387-92.
Cheatle MD, Savage SR. Informed consent in opioid therapy: a potential obligation and opportunity. J
P&SM 2012. 44(1):105-116.
Chou R, et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the
evidence for an American Pain Society and American Academy of Pain Medicine clinical practice
guideline. J Pain. 2009;10(2):147-159.
Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic noncancer pain: a systematic review. J Pain Symptom Manage. 2003 Nov;26(5):1026-48.
Christo PJ et al. Urine drug testing in chronic pain. Pain Physician 2011;14:123-143
Dunn KM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med.
2010 Jan 19;152(2):85-92
Federation of State Medical Boards Guidelines 2004, www.fsmb.org
Fishbain DA et al. Validity of self-reported drug use in chronic pain patients. Clin J Pain 1999
Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S70-5.
Fleming MF et al. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain
2007
Gilron I, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005 Mar
31;352(13):1324-34.
Gomes T, et al. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open
Med. 2011;5(1):e13-22.
Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the
treatment of chronic pain. Pain Med. 2005 Mar-Apr;6(2):107-12.
Heit HA and Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage 2004;27:260-267
Huxtable CA, et al. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth
Intensive Care. 2011 Sep;39(5):804-23.
Katz NP et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid
therapy. Anesth Analg 2003
Kidner CL, et al. Higher opioid doses predict poorer functional outcome in patients with chronic disabling
occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009 Apr;91(4):919-27.
Kobus AM, et al. Correlates of higher-dose opioid medication use for low back pain in primary care. J
Pain. 2012 Nov;13(11):1131-8.
Lee M, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14;145-161.
Manchikanti L et al. Does random urine drug testing reduce illicit drug use in chronic pain patients
receiving opioids? Pain Physician 2006
Nicolaidis C. Police officer, deal-maker, or health care provider? Moving to a patient-centered
framework for chronic opioid management. Pain Med 2011;12(6):890-897.
Passik SD, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving
opioid therapy. Clin Ther. 2004;26:552-561
Paterick TJ, et al. Medical informed consent: general considerations for physicians. Mayo Clin Proc. 2008
Mar;83(3):313-9
Paulozzi LJ. A history of being prescribed controlled substances and risk of drug overdose death. Pain
Med. 2012 Jan;13(1):87-95.
Peppin JF et al. Recommendations for urine drug monitoring as a component of opioid therapy in the
treatment of chronic pain. Pain Medicine 2012;13:886-896.
Pesce A et al. Illicit drug use in the pain patient population decreases with continued drug testing. Pain
Physician 2011
Reisfield GM et al. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
Bioanalysis 2009;1(5):937-952.
Savage SR, Kirsch KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use
disorders. Addict Sci Clin Pract. 2008 June; 4(2): 4–25Starrels J et al. Systematic review: treatment
agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern
Med 2010.
Townsend CO, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program
with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission.
Pain. 2008 Nov 15;140(1):177-89.
Trescot AM et al. Opioids in the management of chronic non-cancer pain: an update of American Society
of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008
Wasan AD et al. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in
chronic pain patients treated with morphine. Clin J Pain 2007
Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management.
Ann Intern Med. 16 March 2004;140(6):441-451.
Module 3
Alford, D. Chronic Back Pain With Possible Prescription Opioid Misuse. JAMA. 2013; Mar 6;309(9):919-25
Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse
Measure. Pain. 2007;130:144-156.
Chang G, et al. Opioid tolerance and hyperalgesia. Med Clin N Am. 2007;91:199-211.
Davies AN et al. The management of cancer-related breakthrough pain: recommendations of a task
group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.
European J of Pain 2009;13:331-338.
Fine PG and Portenoy RK. Establishing "best practices" for opioid rotation: conclusions of an expert
panel. J Pain Symptom Manage 2009;38:418-425.
Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13.
Joseph EK et al. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci.
2010;30(13):4660-4666
Katz N. Patient Level Opioid Risk Management: A Supplement to the PainEDU.org Manual. Newton, MA:
Inflexxion, Inc.; 2007.
Lee M et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-161.
Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006
Mar;104(3):570-87.
Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain
Symptom Manage. 1996 Apr;11(4):203-17.
Pereira J, et al. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term
dosing. J Pain Symptom Manage. 2001 Aug;22(2):672-87.
Portenoy RK and Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases.
Pain 1986; 25(2): 171-186.
Savage SR et al. Definitions related to the medical use of opioids: evolution towards universal
agreement. J Pain Symptom Manage. 2003;26:655-667.
Schug SA, et al. Adverse effects of systemic opioid analgesics. Drug Saf 1992; 7(3):200-213.
Webster LR, Dove B. Avoiding Opioid Abuse While Managing Pain: A Guideline for Practitioners. 1st
Edition. North Branch, MN: Sunrise Press; 2007.
Webster LR, Dove B. Avoiding Opioid Abuse While Managing Pain: A Guideline for Practitioners. 1st
Edition. North Branch, MN: Sunrise Press; 2007.
Webster LR, Fine PG. Review and critique of opioid rotation practices and associated risks of toxicity.
Pain Med. 2012 Apr;13(4):562-70